Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 COVID-19 Study of Opaganib 2021-01-29 20:26
RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease 2021-01-06 20:24
1